Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

POM121L Inhibitors

POM121L inhibitors represent a class of chemical compounds that target the POM121-like (POM121L) protein, which plays a crucial role in the structure and function of the nuclear pore complex (NPC). The NPC is a large multi-protein assembly embedded in the nuclear envelope, acting as a gateway for the regulated exchange of macromolecules between the nucleus and the cytoplasm. POM121L, a transmembrane nucleoporin, is involved in anchoring the nuclear pore to the nuclear envelope, thus ensuring the stability and integrity of the NPC. This protein also contributes to the selective permeability barrier that controls the traffic of RNA, proteins, and other macromolecules. Inhibitors of POM121L interfere with these structural and transport functions by modulating the activity or expression of the protein, potentially altering nuclear-cytoplasmic transport and NPC assembly.

These inhibitors are typically studied in the context of their effects on cellular processes that rely on nuclear-cytoplasmic transport. By disrupting the NPC's structural integrity through POM121L inhibition, cellular processes like gene expression regulation, cell cycle progression, and signal transduction pathways may be influenced. The inhibition of POM121L may also affect the dynamics of chromatin organization and the maintenance of nuclear architecture, given that the NPC is implicated in various genome-related functions. Moreover, studies into POM121L inhibitors often focus on understanding their effects on nuclear pore assembly and the potential impact on cellular homeostasis, which can further elucidate fundamental mechanisms of cell biology, especially regarding nucleocytoplasmic exchange. Through this lens, POM121L inhibitors are important tools for probing the intricacies of nuclear pore function and its relevance to cellular organization.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D inhibits RNA synthesis, potentially impacting the expression of POM121L2 at the transcriptional level.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Triptolide inhibits RNA polymerase and NF-κB, potentially affecting the transcription of POM121L2 and its regulatory pathways.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Flavopiridol inhibits cyclin-dependent kinases, potentially affecting the transcriptional regulation of POM121L2 and its associated pathways.

Triamcinolone acetonide

76-25-5sc-205872
sc-205872A
50 mg
250 mg
$56.00
$149.00
(0)

Triamcinolone acetonide is a glucocorticoid receptor agonist, and its modulation of transcriptional activity may impact the expression of POM121L2.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

α-Amanitin inhibits RNA polymerase II, potentially impacting the transcription of POM121L2 and its downstream targets.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A is a histone deacetylase inhibitor, potentially impacting the epigenetic regulation of POM121L2 expression.

Ellipticine

519-23-3sc-200878
sc-200878A
10 mg
50 mg
$142.00
$558.00
4
(1)

Ellipticine is a DNA-intercalating agent, potentially impacting the transcriptional regulation of POM121L2 and its associated pathways.